JP4444493B2 - カプサイシン受容体およびカプサイシン受容体関連ポリペプチドをコードする核酸配列ならびにその使用 - Google Patents

カプサイシン受容体およびカプサイシン受容体関連ポリペプチドをコードする核酸配列ならびにその使用 Download PDF

Info

Publication number
JP4444493B2
JP4444493B2 JP2000509807A JP2000509807A JP4444493B2 JP 4444493 B2 JP4444493 B2 JP 4444493B2 JP 2000509807 A JP2000509807 A JP 2000509807A JP 2000509807 A JP2000509807 A JP 2000509807A JP 4444493 B2 JP4444493 B2 JP 4444493B2
Authority
JP
Japan
Prior art keywords
capsaicin receptor
capsaicin
polypeptide
receptor
vanilloid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2000509807A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001514879A5 (enExample
JP2001514879A (ja
Inventor
デビッド ジェイ． ジュリアス
マイケル カテリナ
アンソニー ブレイク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of JP2001514879A publication Critical patent/JP2001514879A/ja
Publication of JP2001514879A5 publication Critical patent/JP2001514879A5/ja
Application granted granted Critical
Publication of JP4444493B2 publication Critical patent/JP4444493B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2000509807A 1997-08-20 1998-08-20 カプサイシン受容体およびカプサイシン受容体関連ポリペプチドをコードする核酸配列ならびにその使用 Expired - Lifetime JP4444493B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US91546197A 1997-08-20 1997-08-20
US7215198P 1998-01-22 1998-01-22
US60/072,151 1998-01-22
US08/915,461 1998-01-22
PCT/US1998/017466 WO1999009140A1 (en) 1997-08-20 1998-08-20 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof

Publications (3)

Publication Number Publication Date
JP2001514879A JP2001514879A (ja) 2001-09-18
JP2001514879A5 JP2001514879A5 (enExample) 2006-02-16
JP4444493B2 true JP4444493B2 (ja) 2010-03-31

Family

ID=26753050

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000509807A Expired - Lifetime JP4444493B2 (ja) 1997-08-20 1998-08-20 カプサイシン受容体およびカプサイシン受容体関連ポリペプチドをコードする核酸配列ならびにその使用

Country Status (8)

Country Link
US (3) US6335180B1 (enExample)
EP (1) EP1009804B1 (enExample)
JP (1) JP4444493B2 (enExample)
AT (1) ATE253111T1 (enExample)
AU (1) AU742391B2 (enExample)
CA (1) CA2298540A1 (enExample)
DE (1) DE69819345T2 (enExample)
WO (1) WO1999009140A1 (enExample)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444440B1 (en) 1997-03-07 2002-09-03 Human Genome Sciences, Inc. Vanilloid receptor-2
WO1999009140A1 (en) 1997-08-20 1999-02-25 The Regents Of The University Of California Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
JP2002503451A (ja) * 1998-01-22 2002-02-05 ザ・レジェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニア カプサイシン受容体をコードする核酸配列
WO1999037765A1 (en) * 1998-01-27 1999-07-29 Smithkline Beecham Plc Human vanilloid receptor homologues
EP0943683A1 (en) 1998-03-10 1999-09-22 Smithkline Beecham Plc Human vanilloid receptor homologue Vanilrep1
EP0953638A1 (en) * 1998-03-11 1999-11-03 Synthelabo Human vanilloid receptor-like cation channel
US6906178B2 (en) 1998-08-11 2005-06-14 Human Genome Sciences, Inc. Vanilloid receptor-2
JP2002531069A (ja) * 1998-11-13 2002-09-24 ミレニアム・フアーマシユーチカルズ・インコーポレーテツド タンパク質のカプサイシン／バニロイド受容体ファミリーの新規メンバー及びそれらの使用
US7063951B1 (en) 1998-11-13 2006-06-20 Millennium Pharmaceuticals, Inc. Members of the capsaicin/vanilloid receptor family of proteins and uses thereof
GB9826359D0 (en) * 1998-12-01 1999-01-27 Glaxo Group Ltd Novel receptors
GB9827016D0 (en) 1998-12-08 1999-02-03 Merck Sharp & Dohme Receptor protein
GB9907097D0 (en) * 1999-03-26 1999-05-19 Novartis Ag Organic compounds
WO2000063415A1 (en) * 1999-04-15 2000-10-26 Ortho-Mcneil Pharmaceutical, Inc. Dna encoding the human vanilloid receptor vr1
US6421613B1 (en) * 1999-07-09 2002-07-16 Pioneer Hi-Bred International, Inc. Data processing of the maize prolifera genetic sequence
US6482611B1 (en) 1999-09-23 2002-11-19 Neurogen Corporation Human capsaicin receptor and uses thereof
US6455278B1 (en) * 2000-02-08 2002-09-24 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding human vanilloid receptor VR3
JPWO2001062915A1 (ja) * 2000-02-25 2004-01-08 第一製薬株式会社 新規蛋白質及びそれをコードする遺伝子
NZ524894A (en) 2000-09-02 2005-03-24 Gruenenthal Chemie Antisense oligonucleotides against VR1
DE10043674A1 (de) * 2000-09-02 2002-03-21 Gruenenthal Gmbh Antisense Oligonukleotide
WO2002030937A2 (en) 2000-10-10 2002-04-18 Ortho-Mcneil Pharmaceutical, Inc. Labeled resiniferatoxin derivatives for use in vanilloid receptor binding assay
US6780650B2 (en) 2000-10-16 2004-08-24 Ortho-Mcneil Pharmaceutical, Inc. Ligand binding assays for vanilloid receptors
AU2002232456A1 (en) * 2000-12-01 2002-06-11 Bristol-Myers Squibb Company Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
US20030171275A1 (en) * 2000-12-20 2003-09-11 Baughn Mariah R. Transporters and ion channels
GB0128161D0 (en) * 2001-11-23 2002-01-16 Merck Sharp & Dohme Receptor protein
DK1472225T3 (da) * 2002-02-01 2010-08-09 Euro Celtique Sa 2-Piperazinpyridiner, som er anvendelige til behandling af smerte
ES2541351T3 (es) 2002-02-25 2015-07-17 Vaxiion Therapeutics, Llc Composiciones de minicélulas y procedimientos
US6974818B2 (en) 2002-03-01 2005-12-13 Euro-Celtique S.A. 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
EP1497328A2 (en) * 2002-04-16 2005-01-19 Bayer HealthCare AG Regulation of human transient receptor potential channel
WO2003102156A2 (en) * 2002-05-31 2003-12-11 Sloan-Kettering Institute For Cancer Research Heterologous stimulus-gated ion channels and methods of using same
JP4555082B2 (ja) 2002-08-08 2010-09-29 アムジエン・インコーポレーテツド バニロイド受容体リガンドおよびそれの治療での使用
US20040096089A1 (en) * 2002-08-16 2004-05-20 David Borsook Non-invasive functional imaging of peripheral nervous system activation in humans and animals
US7582635B2 (en) * 2002-12-24 2009-09-01 Purdue Pharma, L.P. Therapeutic agents useful for treating pain
AU2004230915B2 (en) * 2003-04-08 2008-08-07 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
TWI287010B (en) * 2003-06-12 2007-09-21 Euro Celtique Sa Therapeutic agents useful for treating pain
US20050031717A1 (en) * 2003-07-09 2005-02-10 Desimone John A. Salt taste modification
HRP20090404T1 (hr) * 2003-07-24 2009-08-31 Euro-Celtique S.A. Spojevi piperidina i farmaceutski sastavi koji ih sadržavaju
DE602004021206D1 (de) * 2003-07-24 2009-07-02 Euro Celtique Sa Zur Behandlung oder Vorbeugung von Schmerzen geeignete Heteroaryl-Tetrahydropiperidyl-Verbindungen
EP1867644B1 (en) 2003-07-24 2009-05-20 Euro-Celtique S.A. Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
PT1648880E (pt) * 2003-08-01 2010-04-26 Euro Celtique Sa Agentes terapêuticos úteis para o tratamento da dor
PL1664041T3 (pl) * 2003-09-22 2008-12-31 Euro Celtique Sa Przydatne do leczenia bólu związki fenylowo-karboksyamidowe
ES2317052T3 (es) * 2003-09-22 2009-04-16 Euro-Celtique S.A. Agentes terapeuticos utiles para el tratamiento del dolor.
NZ548169A (en) * 2003-12-30 2009-04-30 Euro Celtique Sa Piperazines useful for treating pain
US20070159522A1 (en) * 2004-02-20 2007-07-12 Harmut Neven Image-based contextual advertisement method and branded barcodes
US7751805B2 (en) * 2004-02-20 2010-07-06 Google Inc. Mobile image-based information retrieval system
WO2005087807A1 (en) * 2004-03-09 2005-09-22 Renovis, Inc. Vr1 receptors and uses thereof
GB0412769D0 (en) 2004-06-08 2004-07-07 Novartis Ag Organic compounds
MX2007006253A (es) * 2004-11-24 2007-10-18 Anesiva Inc Formulacion de gel de capsaicinoide y usos para esta.
US8759306B2 (en) * 2005-05-31 2014-06-24 Devgen N.V. RNAi for the control of insects and arachnids
CA2655964C (en) 2006-06-22 2014-10-28 Board Of Regents Of The University Of Nebraska Magnetically coupleable robotic devices and related methods
US8679096B2 (en) 2007-06-21 2014-03-25 Board Of Regents Of The University Of Nebraska Multifunctional operational component for robotic devices
WO2008057300A2 (en) * 2006-10-27 2008-05-15 Redpoint Bio Corporation Trpvi antagonists and uses thereof
JP5372913B2 (ja) 2007-04-27 2013-12-18 パーデュー、ファーマ、リミテッド、パートナーシップ 疼痛治療に有効な治療薬
ES2571533T3 (es) * 2007-04-27 2016-05-25 Purdue Pharma Lp Antagonistas de TRPV1 y usos de los mismos
EP2170564A4 (en) 2007-07-12 2015-10-07 Univ Nebraska ACTUATING PROCESSES AND SYSTEMS IN ROBOTIC EQUIPMENT
US20090076536A1 (en) 2007-08-15 2009-03-19 Board Of Regents Of The University Of Nebraska Medical inflation, attachment, and delivery devices and related methods
WO2009114143A1 (en) * 2008-03-12 2009-09-17 Brown University Treatment and prophylaxis of epilepsy and febrile seizures
US8759362B2 (en) * 2008-10-24 2014-06-24 Purdue Pharma L.P. Bicycloheteroaryl compounds and their use as TRPV1 ligands
US8703962B2 (en) * 2008-10-24 2014-04-22 Purdue Pharma L.P. Monocyclic compounds and their use as TRPV1 ligands
US8546388B2 (en) * 2008-10-24 2013-10-01 Purdue Pharma L.P. Heterocyclic TRPV1 receptor ligands
US8722964B2 (en) * 2009-04-23 2014-05-13 Transposagen Biopharmaceuticals, Inc. Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes
WO2011002988A1 (en) 2009-07-01 2011-01-06 Transposagen Biopharmaceuticals, Inc. Genetically modified rat models for severe combined immunodeficiency (scid)
EP2460016A2 (en) * 2009-07-30 2012-06-06 Transposagen Biopharmaceuticals, Inc. Genetically modified rat models for pharmacokinetics
EP2461672A2 (en) * 2009-08-05 2012-06-13 Transposagen Biopharmaceuticals, Inc. Genetically modified rat models for drug metabolism
EP2467013A2 (en) * 2009-08-20 2012-06-27 Transposagen Biopharmaceuticals, Inc. Genetically modified rat models for pain
US9060781B2 (en) 2011-06-10 2015-06-23 Board Of Regents Of The University Of Nebraska Methods, systems, and devices relating to surgical end effectors
ES2620528T3 (es) 2011-06-22 2017-06-28 Purdue Pharma Lp Antagonistas de TRPV1 que incluyen un sustituyente dihidroxi y usos de los mismos
US9089353B2 (en) 2011-07-11 2015-07-28 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems, and related methods
US9394293B2 (en) 2011-08-10 2016-07-19 Purdue Pharma L.P. TRPV1 antagonists including dihydroxy substituent and uses thereof
JP6502848B2 (ja) 2011-10-03 2019-04-17 ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ モジュール式手術用ロボットシステム
US20140058205A1 (en) 2012-01-10 2014-02-27 Board Of Regents Of The University Of Nebraska Methods, Systems, and Devices for Surgical Access and Insertion
EP4357083A3 (en) 2012-05-01 2024-08-21 Board of Regents of the University of Nebraska Single site robotic device and related systems and methods
EP4234185A3 (en) 2012-06-22 2023-09-20 Board of Regents of the University of Nebraska Local control robotic surgical devices
US9770305B2 (en) 2012-08-08 2017-09-26 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems, and related methods
US12295680B2 (en) 2012-08-08 2025-05-13 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems and related methods
CA2880622C (en) 2012-08-08 2021-01-12 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems and related methods
CA2906672C (en) 2013-03-14 2022-03-15 Board Of Regents Of The University Of Nebraska Methods, systems, and devices relating to force control surgical systems
CA2905948C (en) 2013-03-14 2022-01-11 Board Of Regents Of The University Of Nebraska Methods, systems, and devices relating to robotic surgical devices, end effectors, and controllers
EP4628042A2 (en) 2013-03-15 2025-10-08 Virtual Incision Corporation Robotic surgical devices and systems
CA2918531A1 (en) 2013-07-17 2015-01-22 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems and related methods
MX2016012903A (es) 2014-04-01 2016-12-07 Procter & Gamble Metodos y composiciones para la modificacion de la percepcion sensorial.
EP3868322B1 (en) 2014-09-12 2024-11-20 Board of Regents of the University of Nebraska Quick-release effectors and related systems
CA2967593C (en) 2014-11-11 2024-02-27 Board Of Regents Of The University Of Nebraska Robotic device with compact joint design and related systems and methods
CN114027986B (zh) 2015-08-03 2024-06-14 内布拉斯加大学董事会 机器人手术装置系统及相关方法
CN114098975A (zh) 2016-05-18 2022-03-01 虚拟切割有限公司 机器人外科装置、系统及相关方法
WO2018039606A1 (en) 2016-08-25 2018-03-01 Virtual Incision Corporation Quick-release tool coupler and related systems and methods
CA3035064A1 (en) 2016-08-30 2018-03-08 Board Of Regents Of The University Of Nebraska Robotic device with compact joint design and an additional degree of freedom and related systems and methods
CA3036897C (en) 2016-10-25 2021-11-16 The Procter & Gamble Company Fibrous structures
US10745865B2 (en) 2016-10-25 2020-08-18 The Procter & Gamble Company Creped fibrous structures
CN115337111B (zh) 2016-11-22 2025-04-25 内布拉斯加大学董事会 改进的粗定位装置及相关系统和方法
JP7099728B2 (ja) 2016-11-29 2022-07-12 バーチャル インシジョン コーポレイション ユーザの存在検出機能を備えたユーザコントローラ、関連システムおよび方法
US10722319B2 (en) 2016-12-14 2020-07-28 Virtual Incision Corporation Releasable attachment device for coupling to medical devices and related systems and methods
EP3687370B1 (en) 2017-09-27 2024-11-20 Virtual Incision Corporation Robotic surgical devices with tracking camera technology and related systems
US11013564B2 (en) 2018-01-05 2021-05-25 Board Of Regents Of The University Of Nebraska Single-arm robotic device with compact joint design and related systems and methods
EP3908171A4 (en) 2019-01-07 2022-09-14 Virtual Incision Corporation Robotically assisted surgical system and related devices and methods
CN110045108B (zh) * 2019-05-28 2021-10-29 江南大学 一种基于辣椒碱指标的地沟油酶联免疫检测试剂盒及其检测方法
GB201918103D0 (en) * 2019-12-10 2020-01-22 Oblique Therapeutics Ab Epitopes and antibodies
CA3186863A1 (en) 2020-07-06 2022-01-13 Virtual Incision Corporation Surgical robot positioning system and related devices and methods

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5074977A (en) 1987-05-05 1991-12-24 The Washington Technology Center Digital biosensors and method of using same
DE68926118T2 (de) 1988-08-18 1996-08-22 Australian Membrane And Biotechnology Research Institute Ltd. Commonwealth Scientific And Industrial Research Organization, North Ryde, Neusuedwales Verbesserungen an der empfindlichkeit und der selektivität von ionenkanalmembranbiosensoren
DE69030811T2 (de) 1989-01-27 1997-10-02 Au Membrane & Biotech Res Inst Rezeptormembranen und selektive steuerung des ionenflusses durch ionophoren
US5491097A (en) 1989-06-15 1996-02-13 Biocircuits Corporation Analyte detection with multilayered bioelectronic conductivity sensors
US5328847A (en) 1990-02-20 1994-07-12 Case George D Thin membrane sensor with biochemical switch
US5232684A (en) * 1990-06-29 1993-08-03 The United States Of America As Represented By The Department Of Health And Human Services Labelled resiniferatoxin, compositions thereof, and methods for using the same
WO1999009140A1 (en) 1997-08-20 1999-02-25 The Regents Of The University Of California Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
WO1999037765A1 (en) 1998-01-27 1999-07-29 Smithkline Beecham Plc Human vanilloid receptor homologues
EP0943683A1 (en) 1998-03-10 1999-09-22 Smithkline Beecham Plc Human vanilloid receptor homologue Vanilrep1
EP0953638A1 (en) 1998-03-11 1999-11-03 Synthelabo Human vanilloid receptor-like cation channel
JP2002531069A (ja) 1998-11-13 2002-09-24 ミレニアム・フアーマシユーチカルズ・インコーポレーテツド タンパク質のカプサイシン／バニロイド受容体ファミリーの新規メンバー及びそれらの使用
GB9826359D0 (en) * 1998-12-01 1999-01-27 Glaxo Group Ltd Novel receptors
WO2000063415A1 (en) 1999-04-15 2000-10-26 Ortho-Mcneil Pharmaceutical, Inc. Dna encoding the human vanilloid receptor vr1
EP1144628A3 (en) 1999-11-12 2002-02-27 Abbott Laboratories Human vanilloid receptor gene
AU2001247460A1 (en) 2000-03-15 2001-09-24 Millennium Pharmaceuticals, Inc. 18615 and 48003, human ion channels and uses therefor
JP3501775B2 (ja) 2000-05-31 2004-03-02 ファイザー株式会社 ヒトバニロイド受容体様タンパク質

Also Published As

Publication number Publication date
US7097991B2 (en) 2006-08-29
CA2298540A1 (en) 1999-02-25
WO1999009140A1 (en) 1999-02-25
AU9115698A (en) 1999-03-08
AU742391B2 (en) 2002-01-03
EP1009804A1 (en) 2000-06-21
EP1009804B1 (en) 2003-10-29
DE69819345D1 (de) 2003-12-04
US20030049728A1 (en) 2003-03-13
DE69819345T2 (de) 2004-07-15
US6335180B1 (en) 2002-01-01
EP1009804A4 (en) 2001-05-16
US6790629B2 (en) 2004-09-14
US20050095650A1 (en) 2005-05-05
ATE253111T1 (de) 2003-11-15
JP2001514879A (ja) 2001-09-18

Similar Documents

Publication Publication Date Title
JP4444493B2 (ja) カプサイシン受容体およびカプサイシン受容体関連ポリペプチドをコードする核酸配列ならびにその使用
EP1047711B1 (en) Nucleic acid sequences encoding capsaicin receptors
JP4711512B2 (ja) 新規カリウムチャネルおよび同カリウムチャネルをコードする遺伝子
KR20050042826A (ko) 쥐피알54 넉-아웃 포유류 및 이를 이용한 스크리닝 방법
JP4178028B2 (ja) 受容体
JP2007530069A (ja) イオンチャネル
JP2007530069A6 (ja) イオンチャネル
KR20060036466A (ko) 수용체
KR20060129411A (ko) 이온 채널
US20050119458A1 (en) Novel human proton-gated channels
US6794161B1 (en) Potassium channels and genes encoding these potassium channels
JP4926952B2 (ja) Ｇｐｒ８６受容体の使用
KR20070018987A (ko) 수용체 ｇｐｒ86의 용도
KR20060129503A (ko) 이온 채널
CN1937914A (zh) 离子通道
US20020106721A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
US20050181365A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2007026171A2 (en) Vdcc gamma-8 ion channel
JP2009017784A (ja) カプサイシン受容体の活性調節剤、及びそれを用いた医薬組成物
CA2453655A1 (en) Novel human proton-gated channels
JP2008538907A (ja) イオンチャネル
CA2565014A1 (en) Isolated nucleic acid molecules encoding a novel phosphoprotein-darpp-32, encoded protein and uses thereof
CA2357987A1 (en) Genetic sequence related to bone diseases

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20050407

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050817

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050817

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080716

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081015

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20091221

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100114

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130122

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term